About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
Nichi-Iko Pharmaceutical image

Nichi-Iko Pharmaceutical

Summary
History
Mission
Vision
References
Summaryarrow
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs. It offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products, as well as chemotherapeutic agents. The company also provides treatments for circulatory, digestive, respiratory, nervous system, allergies, and others. It supplies its products to medical institutions, including hospitals, clinics, dispensing pharmacies, etc. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.
Historyarrow

Nichi-Iko was established in Tokyo in 1965. We have grown from a small-scale drug producer to a leading international pharmaceutical company. We have conducted extensive research and development activities to identify and develop novel drugs, medical supplies, and diagnostic imaging equipment. Additionally, we have established subsidiaries and joint-ventures in over 40 countries worldwide. As a result, Nichi-Iko has become one of the largest pharmaceutical companies in Japan and one of the leading companies in the world.

Missionarrow
Our mission is to be a leading international pharmaceutical company, providing innovative treatments and improving the quality of life for people around the world.
Visionarrow
Our vision is to create a healthier world by delivering high-quality and effective treatments to patients, advancing research and development, and collaborating with global healthcare organizations to support access to healthcare.
Referencesarrow

https://in.investing.com/equities/nichi-iko-pharmaceutical

https://finance.yahoo.com/quote/4541.T/profile?p=4541.T

https://www.crunchbase.com/organization/nichi-iko-pharmaceutical

https://www.nichiiko.co.jp

Share

Leadership team
M
Mr. Yuiichi Tamura (Pres, CEO, Representative Director & Compliance Supervisor)
M
Mr. Shuji Ishida (EVP, GM of Admin. Division, Managing Exec. Officer & Director)
H
Hiroshi Shimazaki (Sr. Exec. Officer & Head of Quality Assurance & Pharmacovigilance Division)
Products / Services
Biotechnology, Manufacturing, Pharmaceutical
Number of Employees
1,000 - 20,000
Address
Toyama-shi, Toyama, Japan
Established
1965-01-01
Revenue
$1B+
Traded as
TYO:4541
Website
https://www.nichiiko.co.jp
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo